Literature DB >> 11590125

Defective satellite cells in congenital myotonic dystrophy.

D Furling1, L Coiffier, V Mouly, J P Barbet, J L St Guily, K Taneja, G Gourdon, C Junien, G S Butler-Browne.   

Abstract

In this study we have developed an in vitro cell culture system which displays the majority of the defects previously described for congenital myotonic dystrophy (CDM) muscle in vivo. Human satellite cells were isolated from the quadriceps muscles of three CDM fetuses with different clinical severity. By Southern blot analysis all three cultures were found to have approximately 2300 CTG repeats. This CTG expansion was found to progressively increase in size during the proliferative life span, confirming an instability of this triplet in skeletal muscle cells. The CDM myoblasts and myotubes also showed abnormal retention of mutant RNA in nuclear foci, as well as modifications in their myogenic program. The proliferative capacity of the CDM myoblasts was reduced and a delay in fusion, differentiation and maturation was observed in the CDM cultures compared with unaffected myoblast cultures. The clinical severity and delayed maturation observed in the CDM fetuses were closely reflected by the phenotypic modifications observed in vitro. Since the culture conditions were the same, this suggests that the defects we have described are intrinsic to the program expressed by the myoblasts in the absence of any trophic factors. Altogether, our results demonstrate that satellite cells are defective in CDM and are probably implicated in the delay in maturation and muscle atrophy that has been described previously in CDM fetuses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11590125     DOI: 10.1093/hmg/10.19.2079

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  48 in total

1.  Barx2 is expressed in satellite cells and is required for normal muscle growth and regeneration.

Authors:  Robyn Meech; Katie N Gonzalez; Marietta Barro; Anastasia Gromova; Lizhe Zhuang; Julie-Ann Hulin; Helen P Makarenkova
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

2.  Bidirectional transcription stimulates expansion and contraction of expanded (CTG)*(CAG) repeats.

Authors:  Masayuki Nakamori; Christopher E Pearson; Charles A Thornton
Journal:  Hum Mol Genet       Date:  2010-11-18       Impact factor: 6.150

3.  Selective silencing of mutated mRNAs in DM1 by using modified hU7-snRNAs.

Authors:  Virginie François; Arnaud F Klein; Cyriaque Beley; Arnaud Jollet; Camille Lemercier; Luis Garcia; Denis Furling
Journal:  Nat Struct Mol Biol       Date:  2010-12-26       Impact factor: 15.369

4.  Evaluating the effects of CELF1 deficiency in a mouse model of RNA toxicity.

Authors:  Yun Kyoung Kim; Mahua Mandal; Ramesh S Yadava; Luc Paillard; Mani S Mahadevan
Journal:  Hum Mol Genet       Date:  2013-09-02       Impact factor: 6.150

5.  Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy.

Authors:  Frédérique Rau; Fernande Freyermuth; Charlotte Fugier; Jean-Philippe Villemin; Marie-Christine Fischer; Bernard Jost; Doulaye Dembele; Geneviève Gourdon; Annie Nicole; Denis Duboc; Karim Wahbi; John W Day; Harutoshi Fujimura; Masanori P Takahashi; Didier Auboeuf; Natacha Dreumont; Denis Furling; Nicolas Charlet-Berguerand
Journal:  Nat Struct Mol Biol       Date:  2011-06-19       Impact factor: 15.369

Review 6.  Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.

Authors:  N Muge Kuyumcu-Martinez; Thomas A Cooper
Journal:  Prog Mol Subcell Biol       Date:  2006

7.  Insulin receptor splicing alteration in myotonic dystrophy type 2.

Authors:  R S Savkur; A V Philips; T A Cooper; J C Dalton; M L Moseley; L P W Ranum; J W Day
Journal:  Am J Hum Genet       Date:  2004-04-26       Impact factor: 11.025

8.  Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle.

Authors:  Ian Holt; Virginie Jacquemin; Majid Fardaei; Caroline A Sewry; Gillian S Butler-Browne; Denis Furling; J David Brook; Glenn E Morris
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

9.  Replication inhibitors modulate instability of an expanded trinucleotide repeat at the myotonic dystrophy type 1 disease locus in human cells.

Authors:  Zhi Yang; Rachel Lau; Julien L Marcadier; David Chitayat; Christopher E Pearson
Journal:  Am J Hum Genet       Date:  2003-10-21       Impact factor: 11.025

10.  Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects.

Authors:  Marietta Barro; Gilles Carnac; Sébastien Flavier; Jacques Mercier; Yegor Vassetzky; Dalila Laoudj-Chenivesse
Journal:  J Cell Mol Med       Date:  2008-05-24       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.